The Medical Futurist
JUNE 21, 2025
While it is really difficult to manufacture a contact lens, which is one-third of a millimetre in diameter, a 3D printer sandwiches together different layers of interacting material, which makes it easier to match tiny pieces. The disease is quite common among diabetes patients, and if it is not spotted early enough, it may cause blindness.
Plum Health
AUGUST 30, 2024
Managing diabetes—especially as you get older—can be challenging physically, emotionally, and financially. If you’re living with Type 2 diabetes, you’ve probably heard of Ozempic, Wegovy (semaglutide), Mounjaro or Zepbound (tirzepatide). With Plum Health, managing your diabetes becomes easier, more affordable, and less stressful.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law
JULY 22, 2021
Schlanger — Maine and Nevada previously enacted laws requiring drug manufacturers to report information about the pricing of their products. Both states’ new requirements will become effective in October 2021 and should be considered as manufacturers prepare for state drug price transparency reporting in 2022.
Imperial Center Family Medicine
MAY 26, 2025
In one study , using sesame oil regularly for 90 days significantly improved blood sugar and cholesterol levels in people with diabetes. Sesame Oil Sesame oil contains a compound called sesamin that may help lower LDL cholesterol. Look for unrefined sesame oil to get the most cholesterol-lowering benefits.
GeriPal
MAY 5, 2022
I’d been working with persons who had diabetes and also caregivers and so forth, trying to go at the direction and realize as I look more and more at hearing loss, that it was totally unrecognized in clinical practice. And he liked some of what I was doing, which was really on diabetes and hearing loss. Five big manufacturers.
The Health Policy Exchange
MAY 20, 2013
Food and Drug Administration to market a new drug is a critical waypoint along the path to profits for pharmaceutical manufacturers. In the meantime, lobbyists working for the drug manufacturers successfully blocked efforts by Medicare administrators to stop paying for the higher (harmful) doses. Could the FDA and other U.S.
GeriPal
JUNE 20, 2024
I remember as a geriatric fellow many years ago, we actually diagnosed a patient who had polyuria who ultimately, you know, turned out of diabetes insipidus because when you looked at how much they were avoiding, they were just avoiding way too much. And that can be incredibly powerful. I mean, I can informative.
Expert insights. Personalized for you.
105 
Let's personalize your content